SCHEMBL3407360

SCHEMBL3407360

CCOC(=O)c1nc(-c2ccccn2)c2snc(-c3ccccc3)c2c1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.44
ALDH1A1 P00352 6/20 0.41
MAPT P10636 2/20 0.41
MAPK1 P28482 1/20 0.41
ATM Q13315 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CDC7 O00311 3/20 0.41
DBF4 Q9UBU7 3/20 0.41
ADORA3 P0DMS8 3/20 0.40
HPGD P15428 2/20 0.40
KDM4E B2RXH2 2/20 0.39
APOBEC3G Q9HC16 1/20 0.39
TRPM8 Q7Z2W7 1/20 0.39
RARA P10276 1/20 0.39
RARB P10826 1/20 0.39
RARG P13631 1/20 0.39
GAA P10253 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3407905 0.87 CDC7 (0.53) LMNAALDH1A1MAPTMAPK1ATM
SCHEMBL3401768 0.84 ALDH1A1 (0.49) LMNAALDH1A1MAPTMAPK1ATM
SCHEMBL3780077 0.84 CDC7 (0.48) LMNAALDH1A1MAPTMAPK1ATM
SCHEMBL3401461 0.84 ALDH1A1 (0.51) LMNAALDH1A1MAPTMAPK1ATM
SCHEMBL3407275 0.84 ALDH1A1 (0.51) LMNAALDH1A1MAPTMAPK1ATM
SCHEMBL3405930 0.84 DHODH (0.48) LMNAALDH1A1MAPTHSD17B10ADORA3
SCHEMBL3405938 0.83 DHODH (0.49) LMNAALDH1A1MAPTSMN1; SMN2HSD17B10
SCHEMBL3403370 0.82 ALDH1A1 (0.46) LMNAALDH1A1MAPTMAPK1ATM
SCHEMBL3398339 0.81 ALDH1A1 (0.44) LMNAALDH1A1MAPTMAPK1ATM
SCHEMBL3404472 0.80 APP (0.43) LMNAALDH1A1MAPK1SMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9387200-B2 Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity FIBROGEN, INC. (US) 2016-07-12 US disclosed
US-20150209336-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN, INC. 2015-07-30 US disclosed
US-8952160-B2 Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity FIBROGEN, INC. (US) 2015-02-10 US disclosed
EP-2252619-B1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN INC (US) 2013-10-09 EP disclosed
US-20100330199-A1 ISOTHIAZOLE-PYRIDINE DERIVATES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN, INC. 2010-12-30 US disclosed
EP-2252619-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY Fibrogen, Inc. (US) 2010-11-24 EP disclosed
WO-2009089547-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN, INC. (US) 2009-07-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100330199-A1 ISOTHIAZOLE-PYRIDINE DERIVATES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY HIF1A, HIF1AN, EGLN3 LMNA 4759/4885ALDH1A1 256/4885MAPT 4333/4885
US-20150209336-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY HIF1A, HIF1AN, EGLN3 LMNA 4752/4885ALDH1A1 284/4885MAPT 4408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.